Amber Tong

Amber Tong

Latest

Scientists conduct scientific experiments in the biosafety cabinet of the laboratory .

Innovent Shares Jump on First Profit, Obesity Drug Momentum

March 27, 2026

March 27, 2026

Innovent Shares Jump on First Profit, Obesity Drug Momentum

Scientists conduct scientific experiments in the biosafety cabinet of the laboratory .

March 13, 2026

March 13, 2026

China Approves First Brain Implant for Commercial Use

A Brain-Computer-Interface cap.

March 13, 2026

March 13, 2026

AI Drug Discovery Startup Earendil Is Said to Consider Hong Kong IPO

Glass Vials

March 11, 2026

March 11, 2026

Lilly to Invest $3 Billion in China to Boost Obesity Pill

Lilly Plans To Build New $6.5b Facility In Houston

March 11, 2026

March 11, 2026

Haleon CEO Targets China, India Growth With New Plant, M&A Push

Haleon Plc Chief Executive Officer Brian McNamara Interview

March 6, 2026

March 6, 2026

Pfizer Secures China Nod for Obesity Drug as Generics Loom

Pfizer

February 24, 2026

February 24, 2026

China’s MGI Tech to Divest US Subsidiary Citing Geopolitics

Complete Genomics

February 24, 2026

February 24, 2026

Novo’s Promising China Obesity Drug Records Mid-Stage Trial Win

Novo Nordisk

February 24, 2026

February 24, 2026

Pfizer Nabs China Obesity Drug Rights in $495 Million Deal

Big Pharma Companies in Spain

February 12, 2026

February 12, 2026

Sanofi Pushes Out CEO Paul Hudson After R&D Setbacks

Belén Garijo

February 10, 2026

February 10, 2026

Jack Ma-Backed Ant Bets on AI Health in $69 Billion Sector Race

Ant Group Launches AI Healthcare App AQ In Shanghai

February 10, 2026

February 10, 2026

CSL Shares Tumble to Eight-Year Low After First-Half Profit Miss

After 750% Stock Boom, Australia's Biotech Giant Is Struggling

February 10, 2026

February 10, 2026

CSL CEO McKenzie Steps Down After Board Points to Skills Gap

After 750% Stock Boom, Australia's Biotech Giant Is Struggling

February 9, 2026

February 9, 2026

Lilly Inks Deal with Innovent to Speed Up Early Drug Development

Eli Lilly Digital Health Innovation Hub in Singapore

February 4, 2026

February 4, 2026

AbbVie Shares Fall as Wall Street Focuses on Filler Weakness

Abbvie Ahead Of Earnings Figures

January 30, 2026

January 30, 2026

Astra Signs Obesity Deal in China Worth Up to $18.5 Billion

AstraZeneca branding.

January 29, 2026

January 29, 2026

Astra Touts $15 Billion China Investment During Starmer Trip

AstraZeneca branding

January 20, 2026

January 20, 2026

Ozempic y Wegovy enfrentan una avalancha de genéricos de semaglutida desde China a Brasil

Los medicamentos baratos y regulados se perfilan como uno de los próximos grandes retos del mercado de la pérdida de peso.

Ozempic y Wegovy enfrentan una avalancha de genéricos de semaglutida desde China a Brasil

January 16, 2026

January 16, 2026

Get Ready for Generic Ozempic as a Key Patent Expires

Semaglutide will soon be up for grabs in some countries.

Novo Starts Sale of Weight-Loss Drug Wegovy in Obesity-Hit India

January 14, 2026

January 14, 2026

Generic Ozempic Makers Are Coming to Upend the Obesity Market

Cheap, regulated drugs are shaping up as one of the weight-loss market’s next big challenges.

Generic Ozempic Makers Are Coming to Upend the Obesity Market